China Clinical Trial Exemption and IND Application – Your Questions Answered
Accestra Consulting Group has put together the top 10 most asked questions and answers to China’s clinical trial exemption and IND application (CTA). China’s Center for Drug Evaluation (CDE) allows a drug Marketing Authorization Holder (MAH) to apply for clinical trial exemption in China if a drug is already approved for marketing in…